WIRTH PETER
Insider CIK 1021041 · FMTX Director · SYRS Director · ZLAB Director · GEVA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZLAB Zai Lab Ltd | A Award | 2026-06-17 | 2026-06-22 | 22,371 | — | $0 | 416,121 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2025-06-18 | 2025-06-23 | 10,831 | — | $0 | 393,750 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2024-06-18 | 2024-06-20 | 21,253 | — | $0 | 382,919 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 16,000 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2023-06-29 | 2023-06-30 | 18,903 | $26.45 | $500.0K | 361,666 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 12,000 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2022-12-08 | 2022-12-09 | 3,852 | $35.37 | $136.2K | 342,763 | SEC↗ |
| ZLAB Zai Lab Ltd | S Sale | 2022-12-08 | 2022-12-09 | 4,000 | $35.33 | $141.3K | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 14,026 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 28,053 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 17,533 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 8,375 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | D To issuer deriv | 2022-10-14 | 2022-10-14 | 6,750 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | U Tender | 2022-10-14 | 2022-10-14 | 127,665 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | U Tender | 2022-10-14 | 2022-10-14 | 7,250 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2022-06-08 | 2022-06-09 | 6,750 | — | $0 | 6,750 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award | 2022-06-08 | 2022-06-09 | 4,500 | — | $0 | 134,915 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2022-01-03 | 2022-01-04 | 7,763 | — | $0 | 350,615 | SEC↗ |
| ZLAB Zai Lab Ltd | P Buy | 2021-12-08 | 2022-12-12 | 4,000 | $71.36 | $285.4K | 4,000 | SEC↗ |
| ZLAB Zai Lab Ltd | P Buy | 2021-12-08 | 2021-12-08 | 4,000 | $71.36 | $285.4K | 342,852 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2021-06-17 | 2021-06-21 | 8,375 | — | $0 | 8,375 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award | 2021-06-17 | 2021-06-21 | 2,750 | — | $0 | 130,415 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ZLAB Zai Lab Ltd | A Award | 2021-01-15 | 2021-01-20 | 3,852 | — | $0 | 338,852 | SEC↗ |
| FMTX Forma Therapeutics Holding | S Sale | 2020-06-23 | 2020-06-24 | 9,847 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | S Sale | 2020-06-23 | 2020-06-24 | 25,756 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | S Sale | 2020-06-23 | 2020-06-24 | 10,240 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | S Sale | 2020-06-23 | 2020-06-24 | 18,585 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | P Buy | 2020-06-23 | 2020-06-24 | 63,299 | — | $0 | 127,665 | SEC↗ |
| FMTX Forma Therapeutics Holding | S Sale | 2020-06-23 | 2020-06-24 | 14,026 | — | $0 | 0 | SEC↗ |
| FMTX Forma Therapeutics Holding | A Award deriv | 2020-06-18 | 2020-06-22 | 17,533 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-06-11 | 2020-06-11 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-06-11 | 2019-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-06-14 | 2018-06-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-01-27 | 2017-01-30 | 22,000 | — | $0 | 22,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 15,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2012-06-27 | 2012-06-29 | 15,000 | — | $0 | 15,000 | SEC↗ |